6.020USD-1.31%Mkt Cap: 43.10M $P/E: —1d ago
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally …
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap43.10M $
Enterprise Value43.06M $
Revenue (TTM)85.00K $
Gross Profit-147.00K $
Net Income (TTM)401.00K $
Revenue/Share0.0890 USD
Last Price6.020 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees41
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.46
PEG—
EV/EBITDA-1.77
EV/Revenue506.62
P/S507.03
P/B1.06
EPS (TTM)-48.31
EPS (Forward)-2.45
52W Range
3.8809% of range28.44
52W High28.44 USD
52W Low3.880 USD
Profitability
Gross Margin-207.04%
Oper. Margin-36522.73%
EBITDA Margin0.00%
Profit Margin564.79%
ROE1.18%
ROA1.03%
Growth
Revenue Growth175.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.21M $
CapEx (TTM)31.00K $
FCF Margin-13433.38%
FCF Yield-26.49%
Net Debt10.17M $
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity0.39
Current Ratio2.02
Quick Ratio1.87
Book Value/Sh5.705 USD
Cash/Share0.9550 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateJan 2, 2026
Analyst Consensus
Rating—
Target (Mean)36.00 USD
Upside (mean)+498.0%
Target Range16.00 USD – 56.00 USD
$16.00+498.0% to mean$56.00
# Analysts2
Ownership
Shares Out.7.16M
Float5.20M
Insiders44.15%
Institutions27.52%
Short Interest
Short Ratio1.3d
Short % Float0.64%
Short % Out.0.47%
Shares Short33.65K
Short (prev mo.)8.30K
Technical
SMA 505.826 (+3.3%)
SMA 2009.210 (-34.6%)
Beta0.55
S&P 52W Chg20.25%
Avg Vol (30d)22.66K
Avg Vol (10d)12.62K
Technical Indicators
RSI (14)56.0
MACD0.0170
MACD Signal-0.1252
MACD Hist.+0.1422
BB Upper6.394 USD
BB Middle5.356 USD
BB Lower4.318 USD
BB Width38.75%
ATR (14)0.4918 USD
Vol Ratio (20d)2.07x